St. Clair Advisors’s Pfizer PFE Stock Holding History

St. Clair Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.12M	Hold	39,391	–	–	0.28%	45
2026 Q2	$949K	Hold	39,391	–	–	0.24%	48
2026 Q1	$1.11M	Buy	39,391 +1,088	+3%	+$29K	0.29%	47
2025 Q4	$954K	Buy	38,303 +2,250	+6%	+$56.7K	0.25%	48
2025 Q3	$919K	Buy	36,053 +86	+0.2%	+$2.12K	0.24%	47
2025 Q2	$872K	Hold	35,967	–	–	0.23%	48
2025 Q1	$911K	Hold	35,967	–	–	0.26%	47
2024 Q4	$954K	Hold	35,967	–	–	0.27%	46
2024 Q3	$1.04M	Hold	35,967	–	–	0.3%	44
2024 Q2	$1.01M	Hold	35,967	–	–	0.32%	43
2024 Q1	$998K	Hold	35,967	–	–	0.32%	45
2023 Q4	$1.04M	Sell	35,967 -600	-2%	-$18.1K	0.36%	43
2023 Q3	$1.21M	Hold	36,567	–	–	0.48%	33
2023 Q2	$1.34M	Buy	36,567 +6,246	+21%	+$243K	0.52%	31
2023 Q1	$1.24M	Buy	30,321 +19,070	+169%	+$824K	0.54%	31
2022 Q4	$577K	Buy	+11,251	New	+$539K	0.36%	33

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

St. Clair Advisors's PFE Position: Q3 2026 in Review

St. Clair Advisors held its Pfizer (PFE) position steady in Q3 2026 at 39,391 shares worth $1.12M. The position accounts for 0.28% of the portfolio, ranked #45.

St. Clair Advisors first reported a position in PFE in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.34M in Q2 2023. 881 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

St. Clair Advisors held 39,391 shares of Pfizer worth $1.12M as of Q3 2026.
St. Clair Advisors left its Pfizer share count unchanged in Q3 2026.
Pfizer made up 0.28% of St. Clair Advisors's portfolio in Q3 2026, its #45 holding.
St. Clair Advisors first reported a position in Pfizer in Q4 2022 and has held it in 16 quarters since.
St. Clair Advisors's Pfizer position peaked at $1.34M in Q2 2023.
881 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on St. Clair Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.